Search for content, post, videos

Anocca raises 47 million USD

Reagan Jarvis
Anocca has announced the closing of a USD 47 million (SEK 400 million) Series B financing to further advance the company’s industrialised cellular biology platform and progress its pipeline of TCR-T cellular therapies into Phase I/IIa clinical trials. The financing, led by advisor Danske Bank,
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.